<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1333990" disease_type="Neoplastic Process" abbrv="">Hereditary nonpolyposis colorectal cancer</z:e> HNPCC, <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e>) is a <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disease</z:e> of <z:hpo ids='HP_0000006'>autosomal dominant inheritance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It is caused by a mutation in one of four genes of the DNA mismatch repair system and confers a markedly increased risk for various types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, particularly of the colon and the endometrium </plain></SENT>
<SENT sid="2" pm="."><plain>Its prevalence in the general population is about 1 in 500, and it causes about 2% to 3% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> is diagnosed in two steps: If it is suspected (because a patient develops <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> at an unusually young age or because of familial clustering), the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue is analyzed for evidence of deficient mismatch repair (microsatellite instability, loss of mismatch repair protein expression) </plain></SENT>
<SENT sid="4" pm="."><plain>If such evidence is found, a genetic mutation is sought </plain></SENT>
<SENT sid="5" pm="."><plain>The identification of a pathogenic mutation confirms the diagnosis in the patient and enables predictive testing of other family members </plain></SENT>
<SENT sid="6" pm="."><plain>Diagnostic evaluations for <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> should be carried out with appropriate genetic counseling </plain></SENT>
<SENT sid="7" pm="."><plain>METHOD: Selective literature review </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Prospective cohort studies from Germany, Finland and the Netherlands have shown that <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> detected by systematic colonoscopic surveillance tend to be at an earlier stage than those that are discovered after the patients present with symptoms </plain></SENT>
<SENT sid="9" pm="."><plain>The Finnish study also showed an overall reduction in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk from colonoscopic polypectomy at regular intervals </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: The studies conducted so far have not yet clearly documented the putative benefit of an individualized, risk-adapted surveillance strategy </plain></SENT>
<SENT sid="11" pm="."><plain>Until this is done, patients with <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> and healthy carriers of causative mutations should be monitored with annual colonoscopy and (for women) annual gynecological examination </plain></SENT>
</text></document>